PERK in beta cell biology and insulin biogenesis

Trends Endocrinol Metab. 2010 Dec;21(12):714-21. doi: 10.1016/j.tem.2010.08.005. Epub 2010 Sep 17.


PERK (EIF2AK3) was originally discovered as a major component of the unfolded protein response (UPR). PERK deficiency results in permanent neonatal diabetes, which was initially thought to be caused by a failure to regulate ER stress in insulin-secreting beta cells, culminating in beta cell death. However, subsequent studies found that low beta cell mass was a result of reduced cell proliferation, rather than increased apoptosis. Genetic and cellular studies of Perk-deficient beta cells showed that PERK was crucially required for ER functions including proinsulin trafficking and quality control, unrelated to the ER stress pathway. Under normal physiological conditions, changes in ER calcium levels, mediated by glucose and other insulin secretagogues, regulate PERK activity for the purpose of controlling insulin biogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Insulin / biosynthesis*
  • Insulin-Secreting Cells / enzymology*
  • Models, Biological
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism*


  • Insulin
  • PERK kinase
  • eIF-2 Kinase